Patent details

Basic Information

Publication number:

EP2435041

PCT Application Number:

PCT/EP/2010/057027

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107239675

PCT Publication Number:

WO/2010/136394

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent

French Title of Invention:

Combinaison thérapeutique comprenant un inhibiteur de PLK1 et un agent antinéoplasique

German Title of Invention:

Therapeutische Kombination aus einem PLK1-Hemmer und einem Antineoplastikum

SPC Number:

Dates

Filing date:

21/05/2010

Grant date:

28/12/2016

EP Publication Date:

28/12/2016

PCT Publication Date:

02/12/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/04/2012

EP B1 Publication Date:

28/12/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/05/2017

Expiration date:

21/05/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/05/2010

 

 

Name:

Nerviano Medical Sciences S.r.l.

Address:

11 Viale Pasteur, 10 P.O. Box 11, 20014 Nerviano (MI), Italy (IT)

Inventor

1

Name:

MOLL Juergen

Address:

Italy (IT)

2

Name:

PESENTI Enrico

Address:

Italy (IT)

3

Name:

CIAVOLELLA Antonella

Address:

Italy (IT)

4

Name:

BERIA Italo

Address:

Italy (IT)

5

Name:

BALLINARI Dario

Address:

Italy (IT)

6

Name:

VALSASINA Barbara

Address:

Italy (IT)

Priority

Priority Number:

09161111

Priority Date:

26/05/2009

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/282;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages